Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Opens Door To More Compendium Oversight In Draft White Paper

Executive Summary

A draft white paper examining conflict of interest in the production of drug compendia appears to open the door for more oversight of the publications used for determining coverage of prescription drugs' off-label indications by Medicare and private insurers

You may also be interested in...



Compendia Conflict Of Interest White Paper A Precursor To New Regulations

Compendia publishers can expect to see new regulations regarding transparency and conflict of interest by the end of the year, and those rules could have an effect on whether a compendium will be recognized by CMS as a source for making coverage decisions for off-label drug uses

Compendia Conflict Of Interest White Paper A Precursor To New Regulations

Compendia publishers can expect to see new regulations regarding transparency and conflict of interest by the end of the year, and those rules could have an effect on whether a compendium will be recognized by CMS as a source for making coverage decisions for off-label drug uses

Insurers Call For Greater Transparency In Compendia Process

Third-party payers are looking for greater transparency in the processes that are used to generate compendia that list off-label uses of pharmaceuticals

Related Content

UsernamePublicRestriction

Register

PS050261

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel